• Milklab manufacturer Noumi says if it doesn’t achieve performance targets or fails to defend legal action, the company may not be able to pay its debts or be a viable operation. The legacy of its previous form, as Freedom Foods Group, weighs heavy on the Noumi's future.
    Milklab manufacturer Noumi says if it doesn’t achieve performance targets or fails to defend legal action, the company may not be able to pay its debts or be a viable operation. The legacy of its previous form, as Freedom Foods Group, weighs heavy on the Noumi's future.
Close×

A second class action has been launched action against Freedom Foods and its auditors Deloitte Touche Tohmatsu. The action is backed by litigation funder Omni Bridgeway and run by Phi Finney McDonald.

The first class action was filed by Slater & Gordon in December 2020. Both have been served in the Victorian Supreme Court.

Phi Finney McDonald’s proceedings allege breaches of the Corporations Act 2001 (Cth), Australian Securities and Investments Commission Act and Australian Consumer Law.

In a statement on the case, Phi Finney McDonald said its claim alleges that since 7 December 2014, Freedom Foods improperly capitalised on certain expenses and failed to write off certain inventory, contravening accounting standards. This resulted in the manufacturer “significantly overstating its financial position and performance in annual and half yearly reports”.

Freedom Foods reported more than $590 million in write-downs and almost $175 million loss for FY20, after the board uncovered internal abuse of its equity incentive plan, inventory write-downs and capital expenses not recorded as such.

The company has since sold its underperforming cereals and snacks business to the Arnott’s Group for $20 million. Majority shareholder Arrovest, owned by the Perich family, has committed to invest $200 million in recapitalisation plans for the business after talks with a potential investor collapsed.

Packaging News

Pact Group will delist from the ASX on Wednesday 16 July, the move being the culmination of executive chair and owner Raphael Geminder’s near two-year bid to take full control of the company.

Packaging is at the heart of Suntory’s bold new chapter in Australia, marked by the opening of its $400 million beverage production facility in Swanbank, Queensland – a site purpose-built to deliver high-speed, high-efficiency bottling, canning and kegging through world-class packaging technology and sustainable design.

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.